|
Xoran Technologies LLC
icat xoran software Icat Xoran Software, supplied by Xoran Technologies LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/icat+vision+1%2E62+software/pm25466329-35-16-17?v=Xoran+Technologies+LLC Average 90 stars, based on 1 article reviews
icat xoran software - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
AbbVie Inc
1.62% topical testosterone gel (androgel 1.62%) 1.62% Topical Testosterone Gel (Androgel 1.62%), supplied by AbbVie Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/icat+vision+1%2E62+software/pm39252657-7-15-20?v=AbbVie+Inc Average 90 stars, based on 1 article reviews
1.62% topical testosterone gel (androgel 1.62%) - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
AZBIO CORP
sentence recognition in noise Sentence Recognition In Noise, supplied by AZBIO CORP, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/icat+vision+1%2E62+software/pmc11362525__41467_2024_51514_MOESM1_ESM-447-48-37?v=AZBIO+CORP Average 90 stars, based on 1 article reviews
sentence recognition in noise - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
Gallus BioPharmaceuticals
homolog of gallus gallus double-stranded rna-activated protein kinase Homolog Of Gallus Gallus Double Stranded Rna Activated Protein Kinase, supplied by Gallus BioPharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/icat+vision+1%2E62+software/pmc03534563__1471___2164___13___431___S1-751-7-9?v=Gallus+BioPharmaceuticals Average 90 stars, based on 1 article reviews
homolog of gallus gallus double-stranded rna-activated protein kinase - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
Sony
video camera dxc-151a Video Camera Dxc 151a, supplied by Sony, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/icat+vision+1%2E62+software/pmc03909189-79-27-22?v=Sony Average 90 stars, based on 1 article reviews
video camera dxc-151a - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
Synnovator Inc
tert-butyl 4-(iodomethyl)piperidine-1-carboxylate Tert Butyl 4 (Iodomethyl)piperidine 1 Carboxylate, supplied by Synnovator Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/icat+vision+1%2E62+software/us09708336-2622-21-17?v=Synnovator+Inc Average 90 stars, based on 1 article reviews
tert-butyl 4-(iodomethyl)piperidine-1-carboxylate - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
scion corporation
scion image 1.62a software Scion Image 1.62a Software, supplied by scion corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/icat+vision+1%2E62+software/pmc02592804-101-25-29?v=scion+corporation Average 90 stars, based on 1 article reviews
scion image 1.62a software - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
OriginLab corp
specdis 1.62 Specdis 1.62, supplied by OriginLab corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/icat+vision+1%2E62+software/pmc09228879-164-10-16?v=OriginLab+corp Average 90 stars, based on 1 article reviews
specdis 1.62 - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
scion corporation
version 1.62c capture software Version 1.62c Capture Software, supplied by scion corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/icat+vision+1%2E62+software/pmc03028625-82-20-18?v=scion+corporation Average 90 stars, based on 1 article reviews
version 1.62c capture software - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
Technelysium ltd
chromas version 1.62 Chromas Version 1.62, supplied by Technelysium ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/icat+vision+1%2E62+software/pmc04589764-227-7-10?v=Technelysium+ltd Average 90 stars, based on 1 article reviews
chromas version 1.62 - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
ProMIS Neurosciences
pdds ![]() Pdds, supplied by ProMIS Neurosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/icat+vision+1%2E62+software/pmc09444968-277-64-70?v=ProMIS+Neurosciences Average 90 stars, based on 1 article reviews
pdds - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
Xoran Technologies LLC
xoran 3.1.62 ![]() Xoran 3.1.62, supplied by Xoran Technologies LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/icat+vision+1%2E62+software/pmc08601496-70-2-4?v=Xoran+Technologies+LLC Average 90 stars, based on 1 article reviews
xoran 3.1.62 - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Multiple sclerosis and related disorders
Article Title: The impact of socioeconomic status on subsequent neurological outcomes in multiple sclerosis
doi: 10.1016/j.msard.2022.103994
Figure Lengend Snippet: American Community Survey data from 2011–2015 (referred as 2015) provided neighborhood socioeconomic status as the exposure. Patient-reported outcomes (MSRS-R, PDDS, PROMIS-physical function) surveyed during the most recent year between 2018 and 2020 provided the clinically relevant neurological and physical functional assessment. CUIMC, Columbia University Irving Medical Center. PROMOTE, Prospective Investigation of Multiple Sclerosis in the Three Rivers Region. This figure was created with BioRender.com.
Article Snippet: Estimate 1 95% CI 2 P-Value 3 N 4 Neighborhood Median Household Income MSRS-R −3.80e-05 −5.05e-05, −2.56e-05 <0.001 1665 PDDS −8.58e-06 −1.28e-05, −4.32e-06 <0.001 1646 PROMIS 2.55e-05 5.96e-07, 5.05e-05 0.044 1020 Neighborhood Median Home Value MSRS-R −6.50e-06 −8.16e-06, −4.84e-06 <0.001 1666 PDDS −1.54e-06 −2.11e-06, −9.65e-07 <0.001 1647 PROMIS 4.98e-06 1.81e-06, 8.14e-06 0.00209 1021 Neighborhood Percent with College Education MSRS-R −7.31 −8.99, −5.64 <0.001 1668
Techniques: Functional Assay
Journal: Multiple sclerosis and related disorders
Article Title: The impact of socioeconomic status on subsequent neurological outcomes in multiple sclerosis
doi: 10.1016/j.msard.2022.103994
Figure Lengend Snippet: Participant characteristics
Article Snippet: Estimate 1 95% CI 2 P-Value 3 N 4 Neighborhood Median Household Income MSRS-R −3.80e-05 −5.05e-05, −2.56e-05 <0.001 1665 PDDS −8.58e-06 −1.28e-05, −4.32e-06 <0.001 1646 PROMIS 2.55e-05 5.96e-07, 5.05e-05 0.044 1020 Neighborhood Median Home Value MSRS-R −6.50e-06 −8.16e-06, −4.84e-06 <0.001 1666 PDDS −1.54e-06 −2.11e-06, −9.65e-07 <0.001 1647 PROMIS 4.98e-06 1.81e-06, 8.14e-06 0.00209 1021 Neighborhood Percent with College Education MSRS-R −7.31 −8.99, −5.64 <0.001 1668
Techniques: Biomarker Discovery
Journal: Multiple sclerosis and related disorders
Article Title: The impact of socioeconomic status on subsequent neurological outcomes in multiple sclerosis
doi: 10.1016/j.msard.2022.103994
Figure Lengend Snippet: PROs included MSRS-R median score, PROMIS-physical function median T-scores, and proportion of people with PDDS median score dichotomized according to full-time requirement for ambulation assistance versus otherwise (PDDS≥4 versus <4), all from the latest year between 2018 and 2020.
Article Snippet: Estimate 1 95% CI 2 P-Value 3 N 4 Neighborhood Median Household Income MSRS-R −3.80e-05 −5.05e-05, −2.56e-05 <0.001 1665 PDDS −8.58e-06 −1.28e-05, −4.32e-06 <0.001 1646 PROMIS 2.55e-05 5.96e-07, 5.05e-05 0.044 1020 Neighborhood Median Home Value MSRS-R −6.50e-06 −8.16e-06, −4.84e-06 <0.001 1666 PDDS −1.54e-06 −2.11e-06, −9.65e-07 <0.001 1647 PROMIS 4.98e-06 1.81e-06, 8.14e-06 0.00209 1021 Neighborhood Percent with College Education MSRS-R −7.31 −8.99, −5.64 <0.001 1668
Techniques:
Journal: Multiple sclerosis and related disorders
Article Title: The impact of socioeconomic status on subsequent neurological outcomes in multiple sclerosis
doi: 10.1016/j.msard.2022.103994
Figure Lengend Snippet: Covariate-adjusted regression analysis using area deprivation index in 2015 as the exposure and the median scores of patient-reported outcomes of neurological and physical function from the latest year between 2018 and 2020.
Article Snippet: Estimate 1 95% CI 2 P-Value 3 N 4 Neighborhood Median Household Income MSRS-R −3.80e-05 −5.05e-05, −2.56e-05 <0.001 1665 PDDS −8.58e-06 −1.28e-05, −4.32e-06 <0.001 1646 PROMIS 2.55e-05 5.96e-07, 5.05e-05 0.044 1020 Neighborhood Median Home Value MSRS-R −6.50e-06 −8.16e-06, −4.84e-06 <0.001 1666 PDDS −1.54e-06 −2.11e-06, −9.65e-07 <0.001 1647 PROMIS 4.98e-06 1.81e-06, 8.14e-06 0.00209 1021 Neighborhood Percent with College Education MSRS-R −7.31 −8.99, −5.64 <0.001 1668
Techniques:
Journal: Multiple sclerosis and related disorders
Article Title: The impact of socioeconomic status on subsequent neurological outcomes in multiple sclerosis
doi: 10.1016/j.msard.2022.103994
Figure Lengend Snippet: Area deprivation index in 2015 was the exposure for the median scores of the patient-reported outcomes of neurological and physical function from the latest year between 2018 and 2020. Higher scores of MS symptom burden (MSRS-R), higher scores of gait impairment (PDDS) and lower T-scores of PROMIS-physical function indicated greater neurological and/or physical disability. Each square was the standardized β coefficient, and each line was the 95% confidence interval (95%-CI). The diamond represented the meta-analyzed β coefficient and 95% CI in a random-effects meta-analysis of the two cohorts. Higher ADI was associated with subsequently greater MSRS-R and PDDS. The significance threshold for multiple testing was p=0.0167.
Article Snippet: Estimate 1 95% CI 2 P-Value 3 N 4 Neighborhood Median Household Income MSRS-R −3.80e-05 −5.05e-05, −2.56e-05 <0.001 1665 PDDS −8.58e-06 −1.28e-05, −4.32e-06 <0.001 1646 PROMIS 2.55e-05 5.96e-07, 5.05e-05 0.044 1020 Neighborhood Median Home Value MSRS-R −6.50e-06 −8.16e-06, −4.84e-06 <0.001 1666 PDDS −1.54e-06 −2.11e-06, −9.65e-07 <0.001 1647 PROMIS 4.98e-06 1.81e-06, 8.14e-06 0.00209 1021 Neighborhood Percent with College Education MSRS-R −7.31 −8.99, −5.64 <0.001 1668
Techniques:
Journal: Multiple sclerosis and related disorders
Article Title: The impact of socioeconomic status on subsequent neurological outcomes in multiple sclerosis
doi: 10.1016/j.msard.2022.103994
Figure Lengend Snippet: The significant ADI components in 2015 included neighborhood median household income (A-C), neighborhood median home value (D-F), and neighborhood percent with college education (G-I) within the zip code of a participant’s residential address. The PROs included the median scores of MSRS-R, PDDS, and PROMIS-physical function from the latest year between 2018 and 2020.
Article Snippet: Estimate 1 95% CI 2 P-Value 3 N 4 Neighborhood Median Household Income MSRS-R −3.80e-05 −5.05e-05, −2.56e-05 <0.001 1665 PDDS −8.58e-06 −1.28e-05, −4.32e-06 <0.001 1646 PROMIS 2.55e-05 5.96e-07, 5.05e-05 0.044 1020 Neighborhood Median Home Value MSRS-R −6.50e-06 −8.16e-06, −4.84e-06 <0.001 1666 PDDS −1.54e-06 −2.11e-06, −9.65e-07 <0.001 1647 PROMIS 4.98e-06 1.81e-06, 8.14e-06 0.00209 1021 Neighborhood Percent with College Education MSRS-R −7.31 −8.99, −5.64 <0.001 1668
Techniques:
Journal: Multiple sclerosis and related disorders
Article Title: The impact of socioeconomic status on subsequent neurological outcomes in multiple sclerosis
doi: 10.1016/j.msard.2022.103994
Figure Lengend Snippet: Covariate-adjusted regression analysis of individual driving components of the area deprivation index (ADI) in 2015 as the exposure and median scores of patient-reported outcomes of neurological function from the latest year between 2018 and 2020 from the joint cohorts.
Article Snippet: Estimate 1 95% CI 2 P-Value 3 N 4 Neighborhood Median Household Income MSRS-R −3.80e-05 −5.05e-05, −2.56e-05 <0.001 1665 PDDS −8.58e-06 −1.28e-05, −4.32e-06 <0.001 1646 PROMIS 2.55e-05 5.96e-07, 5.05e-05 0.044 1020 Neighborhood Median Home Value MSRS-R −6.50e-06 −8.16e-06, −4.84e-06 <0.001 1666 PDDS −1.54e-06 −2.11e-06, −9.65e-07 <0.001 1647 PROMIS 4.98e-06 1.81e-06, 8.14e-06 0.00209 1021 Neighborhood Percent with College Education MSRS-R −7.31 −8.99, −5.64 <0.001 1668
Techniques:
Journal: Multiple sclerosis and related disorders
Article Title: The impact of socioeconomic status on subsequent neurological outcomes in multiple sclerosis
doi: 10.1016/j.msard.2022.103994
Figure Lengend Snippet: Indirect effects of neighborhood-level health insurance coverage (percent of population with private or Medicaid insurance within the neighborhood of the participant’s home residence) in 2015 on mediating the covariate-adjusted association between area deprivation index in 2015 and the median scores of patient-reported outcomes of neurological and physical function from the latest year between 2018 and 2020 from the joint cohorts.
Article Snippet: Estimate 1 95% CI 2 P-Value 3 N 4 Neighborhood Median Household Income MSRS-R −3.80e-05 −5.05e-05, −2.56e-05 <0.001 1665 PDDS −8.58e-06 −1.28e-05, −4.32e-06 <0.001 1646 PROMIS 2.55e-05 5.96e-07, 5.05e-05 0.044 1020 Neighborhood Median Home Value MSRS-R −6.50e-06 −8.16e-06, −4.84e-06 <0.001 1666 PDDS −1.54e-06 −2.11e-06, −9.65e-07 <0.001 1647 PROMIS 4.98e-06 1.81e-06, 8.14e-06 0.00209 1021 Neighborhood Percent with College Education MSRS-R −7.31 −8.99, −5.64 <0.001 1668
Techniques:
Journal: Multiple sclerosis and related disorders
Article Title: The impact of socioeconomic status on subsequent neurological outcomes in multiple sclerosis
doi: 10.1016/j.msard.2022.103994
Figure Lengend Snippet: Covariate-adjusted regression analysis using nine individual household income brackets ranging from “$0 to $19,999” to “$125,000 or higher” and the patient-reported outcomes of neurological and physical function for each participant in a subgroup analysis of joint cohorts that accounted for the area deprivation index.
Article Snippet: Estimate 1 95% CI 2 P-Value 3 N 4 Neighborhood Median Household Income MSRS-R −3.80e-05 −5.05e-05, −2.56e-05 <0.001 1665 PDDS −8.58e-06 −1.28e-05, −4.32e-06 <0.001 1646 PROMIS 2.55e-05 5.96e-07, 5.05e-05 0.044 1020 Neighborhood Median Home Value MSRS-R −6.50e-06 −8.16e-06, −4.84e-06 <0.001 1666 PDDS −1.54e-06 −2.11e-06, −9.65e-07 <0.001 1647 PROMIS 4.98e-06 1.81e-06, 8.14e-06 0.00209 1021 Neighborhood Percent with College Education MSRS-R −7.31 −8.99, −5.64 <0.001 1668
Techniques: